TARGETING TFE3 FUSION PROTEINS USING PROTAC IN TRANSLOCATION RENAL CELL CARCINOMA (TRCC)

$178,999FY2025Defense Health AgencyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →